...
【24h】

A Novel Prediction Model for Bloodstream Infections in Hepatobiliary-Pancreatic Surgery Patients

机译:肝胆胰腺手术患者血流感染的新预测模型

获取原文
获取原文并翻译 | 示例

摘要

BackgroundBloodstream infections (BSI) are an important source of postoperative mortality in hepatobiliary-pancreatic surgery (HBPS) patients, and no prediction model has been analyzed before.MethodsUsing big data from the electronic medical records of the administrative and culture databases of MacKay Memorial Hospital, we identified the potential risk factors for community-acquired and healthcare-associated BSI and mortality of patients who received HBPS. Subsequently, we analyzed the microorganisms' profiles and antimicrobial susceptibility patterns for these BSI.ResultsBSI were found in 6.3% patients (349 of 5513 HBPS patients), and hospital mortality was 1.48% (82 of 5513). Dividing patients into low-, intermediate-, and high-risk groups on the basis of sex, age, status of comorbidity (renal failure, peptic ulcer disease, fluid and electrolyte disorders, and acute cholecystitis), a predictive BSI risk score model was developed. According to this model, BSI risk ranged from 1.43% to 11.95%; AUROC to predict BSI risk was 0.72 (95% CI 0.69-0.75). From this retrospective study, Enterobacteriaceae were the most common microorganisms that were isolated from BSI. For both community-acquired and healthcare-associated BSI, imipenem and colistin are the most successful.ConclusionThis novel model can be useful to predict who is at risk of BSI after HBPS, and new prophylactic protocols for these patients are needed.
机译:BackgroundBrooctReam感染(BSI)是肝胆胰腺手术(HBPS)患者术后死亡率的重要来源,并且在Mackay纪念医院的行政和文化数据库的电子医疗记录中没有分析预测模型。我们确定了社区获得的和医疗保健相关BSI的潜在危险因素和接待HBP的患者的死亡率。随后,我们分析了微生物的谱和抗微生物易感性模式,这些BSI.Resultsbsi在6.3%的患者(349名5513 Hbps患者中),医院死亡率为1.48%(5513个中的82个)。将患者分为低,中间和高风险群体,年龄,合并症的状态(肾衰竭,消毒性溃疡病,液体和电解质障碍,急性胆囊炎),预测BSI风险得分模型是发达。根据该模型,BSI风险从1.43%到11.95%; Auroc预测BSI风险为0.72(95%CI 0.69-0.75)。从这个回顾性研究,肠杆菌属植物是从BSI中分离的最常见的微生物。对于社区获得的和医疗相关的BSI,Imipenem和Colistin是最成功的。结论该新型模型可用于预测Hbps后BSI风险的预测,并且需要新的预防性方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号